Vivos Therapeutics Statistics Share Statistics Vivos Therapeutics has 5.89M
shares outstanding. The number of shares has increased by 23.59%
in one year.
Shares Outstanding 5.89M Shares Change (YoY) 23.59% Shares Change (QoQ) 0% Owned by Institutions (%) 6.1% Shares Floating 3.19M Failed to Deliver (FTD) Shares 616 FTD / Avg. Volume 0.08%
Short Selling Information The latest short interest is 260.24K, so 3.47% of the outstanding
shares have been sold short.
Short Interest 260.24K Short % of Shares Out 3.47% Short % of Float 3.76% Short Ratio (days to cover) 2.57
Valuation Ratios The PE ratio is -1.93 and the forward
PE ratio is -2.5.
Vivos Therapeutics's PEG ratio is
0.02.
PE Ratio -1.93 Forward PE -2.5 PS Ratio 1.43 Forward PS 0.7 PB Ratio 2.71 P/FCF Ratio -1.62 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vivos Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.5,
with a Debt / Equity ratio of 0.19.
Current Ratio 1.5 Quick Ratio 1.5 Debt / Equity 0.19 Debt / EBITDA -0.14 Debt / FCF -0.11 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $137.9K Profits Per Employee $-102.17K Employee Count 109 Asset Turnover 0.98 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 15.56% in the
last 52 weeks. The beta is 6.99, so Vivos Therapeutics's
price volatility has been higher than the market average.
Beta 6.99 52-Week Price Change 15.56% 50-Day Moving Average 4.33 200-Day Moving Average 3.75 Relative Strength Index (RSI) 33.58 Average Volume (20 Days) 810,403
Income Statement In the last 12 months, Vivos Therapeutics had revenue of 15.03M
and earned -11.14M
in profits. Earnings per share was -2.22.
Revenue 15.03M Gross Profit 9.02M Operating Income -11.17M Net Income -11.14M EBITDA -10.55M EBIT -11.17M Earnings Per Share (EPS) -2.22
Full Income Statement Balance Sheet The company has 6.26M in cash and 1.51M in
debt, giving a net cash position of 4.75M.
Cash & Cash Equivalents 6.26M Total Debt 1.51M Net Cash 4.75M Retained Earnings -104.19M Total Assets 26.03M Working Capital 304K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -12.69M
and capital expenditures -568K, giving a free cash flow of -13.26M.
Operating Cash Flow -12.69M Capital Expenditures -568K Free Cash Flow -13.26M FCF Per Share -2.64
Full Cash Flow Statement Margins Gross margin is 60%, with operating and profit margins of -74.32% and -74.09%.
Gross Margin 60% Operating Margin -74.32% Pretax Margin -74.09% Profit Margin -74.09% EBITDA Margin -70.22% EBIT Margin -74.32% FCF Margin -88.21%
Dividends & Yields VVOS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for VVOS is $6.25,
which is 100.3% higher than the current price. The consensus rating is "Strong Buy".
Price Target $6.25 Price Target Difference 100.3% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 27, 2023. It was a
backward
split with a ratio of 1:25.
Last Split Date Oct 27, 2023 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -6.75 Piotroski F-Score 0
